First clinical findings indicating that inhibiting FAS in individuals with obesity using TVB-2640 suppresses liver DNL with minimal adverse events
GHK-Cu is a copper-binding peptide with a different focus
Understanding the scientific background behind these peptides is essential for navigating conversations responsibly and accurately
BPC-157 is available through medical providers who work with licensed 503A compounding pharmacies
Wen PY, Reardon DA, Forst DA, Lee EQ, Haas B, Daoud T, et al
The VITAL trial, which randomized over 25,000 participants to vitamin D3 2000 IU daily or placebo, found no reduction in major cardiovascular events over 5.3 years of follow-up